Ultimately, tumours with PD-L1 negative tumour cells still had positive effect of anti PD-1 therapy, demonstrating that the treatment effect could effectively mediated through the inhibition of PD-1/PD-L1 pathway on immune cells [81]. The gene discussed is CD274; the disease is neoplasm.